DNA Electrochemistry: Charge-Transport Pathways through DNA Films on Gold.

Over the past 25 years, collective evidence has demonstrated that the DNA base-pair stack serves as a medium for charge transport chemistry in solution and on DNA-modified gold surfaces. Since this charge transport depends sensitively upon the integrity of the DNA base pair stack, perturbations in base stacking, as may occur with DNA base mismatches, lesions, and protein binding, interrupt DNA charge transport (DNA CT). This sensitivity has led to the development of powerful DNA electrochemical sensors. Given the utility of DNA electrochemistry for sensing and in response to recent literature, we describe critical protocols and characterizations necessary for performing DNA-mediated electrochemistry. We demonstrate DNA electrochemistry with a fully AT DNA sequence using a thiolated preformed DNA duplex and distinguish this DNA-mediated chemistry from that of electrochemistry of largely single-stranded DNA adsorbed to the surface. We also demonstrate the dependence of DNA CT on a fully stacked duplex. An increase in the percentage of mismatches within the DNA monolayer leads to a linear decrease in current flow for a DNA-bound intercalator, where the reaction is DNA-mediated; in contrast, for ruthenium hexammine, which binds electrostatically to DNA and the redox chemistry is not DNA-mediated, there is no effect on current flow with mismatches. We find that, with DNA as a well hybridized duplex, upon assembly, a DNA-mediated pathway facilitates the electron transfer between a well coupled redox probe and the gold surface. Overall, this report highlights critical points to be emphasized when utilizing DNA electrochemistry and offers explanations and controls for analyzing confounding results.

Rhodium Complexes Targeting DNA Mismatches as a Basis for New Therapeutics in Cancers Deficient in Mismatch Repair.

Cancers with microsatellite instability (MSI), which include ≤20% of solid tumors, are characterized by resistance to chemotherapy due to deficiency in the DNA mismatch repair (MMR) pathway. Rhodium metalloinsertors make up a class of compounds that bind DNA mismatches with high specificity and show selective cytotoxicity in MSI cancer cells. We determined that rhodium complexes with an N∧O coordination showed significantly increased cell potency compared with that of N∧N-coordinated compounds, and we identified [Rh(chrysi)(phen)(PPO)]2+ (RhPPO) as the most potent, selective compound in this class. Using matched cell lines that are MMR-deficient (HCT116O) and MMR-proficient (HCT116N), we demonstrated that RhPPO preferentially activates the DNA damage response and inhibits DNA replication and cell proliferation in HCT116O cells, leading to cell death by necrosis. Using a fluorescent conjugate of RhPPO, we established that the metalloinsertor localizes to DNA mismatches in the cell nucleus and causes DNA double-strand breaks at or near the mismatch sites. Evaluation of RhPPO across MMR-deficient and MMR-proficient cell lines confirmed the broad potential for RhPPO to target MSI cancers, with cell potency significantly higher than that of platinum complexes used broadly as chemotherapeutics. Moreover, in a mouse xenograft model of MSI cancer, RhPPO shows promising antitumor activity and increased survival. Thus, our studies indicate that RhPPO is a novel DNA-targeted therapy with improved potency and selectivity over standard-of-care platinum-based chemotherapy and, importantly, that DNA mismatches offer a critical new target in the design of chemotherapeutics for MSI cancers.

Cell-Selective Cytotoxicity of a Fluorescent Rhodium Metalloinsertor Conjugate Results from Irreversible DNA Damage at Base Pair Mismatches.

Up to 20% of solid tumors are characterized by DNA mismatch repair (MMR) deficiency and microsatellite instability that confer resistance to standard of care chemotherapy. MMR-deficient cancers have an increased mutation rate, and DNA mismatches accumulate as part of these cancers. We previously described a class of compounds, rhodium metalloinsertors, that bind DNA mismatches with high specificity and selectivity and have potential as targeted therapy. [Rh(chrysi)(phen)(PPO)]2+ (RhPPO) is the most potent, selective compound in this class and acts by targeting DNA mismatches, resulting in preferential cytotoxicity to MMR-deficient cancers. To explore further the cellular mechanism of action of RhPPO, we conjugated the metal complex to a fluorescent probe, cyanine 3 (Cy3). RhPPO-Cy3 binds DNA mismatches and retains the selectivity and potent cytotoxic activity of RhPPO for MMR-deficient cell lines. RhPPO-Cy3 forms discrete foci in the cell nucleus that overlap with sites of DNA damage, suggesting that the lesions occur at or near DNA mismatch sites. RhPPO-Cy3 foci persist over time, despite initial processing of the lesion and recruitment of repair proteins, consistent with the idea that the complex binding to a mismatch prevents repair. RhPPO-Cy3 binding does not lead to activation of p53 and the apoptotic pathway. Together, these findings support the idea that RhPPO-Cy3 binding leads to irreversible DNA damage at DNA mismatches that enables selective cytotoxicity to MMR-deficient cells.

Cellular Target of a Rhodium Metalloinsertor is the DNA Base Pair Mismatch.

Defects in DNA mismatch repair (MMR) are commonly found in various cancers, especially in colorectal cancers. Despite the high prevalence of MMR-deficient cancers, mismatch-targeted therapeutics are limited and diagnostic tools are indirect. Here, we examine the cytotoxic properties of a rhodium metalloinsertor, [Rh(phen)(chrysi)(PPO)]2+ (RhPPO) in 27 diverse colorectal cancer cell lines. Despite the low frequency of genomic mismatches and the non-covalent nature of the RhPPO-DNA lesion, RhPPO is on average five times more potent than cisplatin. Importantly, the biological target and profile for RhPPO differs from that of cisplatin. A fluorescent metalloinsertor, RhCy3, was used to demonstrate that the cellular target of RhPPO is the DNA mismatch. RhCy3 represents a direct probe for MMR-deficiency and correlates directly with the cytotoxicity of RhPPO across different cell lines. Overall, our studies clearly indicate that RhPPO and RhCy3 are promising anticancer and diagnostic probes for MMR-deficient cancers, respectively.

Homo- and Heteropolymetallic Complexes of the Hybrid, Ambidentate N-Heterocyclic Carbene Ligand IMes-acac.

The anionic 5-acetylimidazol-2-ylidene-4-olate 1 -, named as "IMes-acac", is composed of fused diaminocarbene and acetylacetonato units in the same IMes-based imidazolyl ring. The bifunctional compound 1 - is shown to act as an effective, ditopic bridging ligand for transition metal centers. Several new complexes supported by this ligand were prepared, including the complex [RuCl(p-Cym)(κ2 O,O-1·H)](BF4) (2), which can be regarded as a metallated imidazolium salt, the homobimetallic complex [((COD)Rh)(RhCl(COD))(µ-1κ2 O,O:2κ1 C-1)] (4), the heterobimetallic complexes [((p-Cym)ClRu)(RhCl(COD))(µ-1κ2 O,O:2κ1 C-1)] (3), [((p-Cym)ClRu)(RhCl(CO)2)(µ-1κ2 O,O:2κ1 C-1)] (5), [((p-Cym)ClRu)(Cu(IPr))(µ-1κ2 O,O:2κ1 C-1)] (9), the anionic homoleptic Cu(I) complexes [Cu(κ1 C-1)2]K ([10]K) and [Cu(κ1 C-1)2](NEt4) ([10](NEt4)), and the heterotrimetallic complex [((p-Cym)RuCl)2(Cu)(µ-1κ2 O,O:3κ1 C-1)(µ-2κ2 O,O:3κ1 C-1)](PF6) (11). Preliminary studies on the possible preparation of supramolecular metallopolymers and electrochemical studies on the series of complexes are also reported.

A Rhodium-Cyanine Fluorescent Probe: Detection and Signaling of Mismatches in DNA.

We report a bifunctional fluorescent probe that combines a rhodium metalloinsertor with a cyanine dye as the fluorescent reporter. The conjugate shows weak luminescence when free in solution or with well matched DNA but exhibits a significant luminescence increase in the presence of a 27-mer DNA duplex containing a central CC mismatch. DNA photocleavage experiments demonstrate that, upon photoactivation, the conjugate cleaves the DNA backbone specifically near the mismatch site on a 27-mer fragment, consistent with mismatch targeting. Fluorescence titrations with the 27-mer duplex containing the CC mismatch reveal a DNA binding affinity of 3.1 × 106 M-1, similar to that of other rhodium metalloinsertors. Fluorescence titrations using genomic DNA extracted from various cell lines demonstrate a clear discrimination in fluorescence between those cell lines that are proficient or deficient in mismatch repair. This differential luminescence reflects the sensitive detection of the mismatchrepair-deficient phenotype.

Color-Tunable Heterodinuclear Pt(II)/B(III) and Pt(II)/Ir(III) Arrays with N

The synthesis and photophysical properties of two multichromophoric systems, Pt(II)/B(III) and Pt(II)/Ir(III), based on novel N^O-julolidine ligands are reported. The functionalization of the julolidine core enables the introduction of two different anchoring sites, a terminal acetylene and an N^O chelating moiety, which allow the assembling of two different chromophoric centers. The complex photophysical behavior of these multicomponent arrays is rationalized by investigating a series of model compounds, which are prepared through specific synthetic pathways. The photophysical properties of the final multicomponent arrays are investigated in parallel with the models. The multichromophoric system, composed by a platinum(II) and an iridium(III) chromophore connected through a modified julolidine ditopic ligand, displays a peculiar excitation wavelength dependent luminescence behavior. It exhibits tuning of the emission color from blue to orange, passing through pure and warm white.

Panchromatic luminescence from julolidine dyes exhibiting excited state intramolecular proton transfer.

The preparation and the photophysical behaviour of novel julolidine derivatives designed for displaying excited state intramolecular proton transfer (ESIPT) are reported. These dyes exhibit panchromatic photoluminescence covering the whole visible spectral range, both in organic solvents and in the solid state.

IMes-acac: hybrid combination of diaminocarbene and acetylacetonato sub-units into a new anionic ambidentate NHC ligand.

The mesoionic 5-acetylimidazolium-4-olate serves as precursor for an anionic, hybrid NHC, "IMes-acac", consisting of fused diaminocarbene and acetylacetonato units, whose respective coordination abilities are evaluated by the formation of a series of representative copper(I) complexes illustrating the ambidentate character of the ligand.

A hybrid bis(amino-styryl) substituted Bodipy dye and its conjugate diacid: synthesis, structure, spectroscopy and quantum chemical calculations.

A new type of fluorescent pH indicator has been developed whereby two dissimilar amino-styryl units are attached to a boron dipyrromethene (Bodipy) dye. The photophysical properties of this hybrid dye, and its simpler counterparts bearing only a single amino-styryl residue, depend on the polarity of the surrounding medium. Of the two terminal amines, DFT (B3LYP/6-31G**) calculations and spectroscopic measurements support the notion that julolidine is oxidised and protonated under milder conditions than is N,N-dimethylaniline. For the hybrid dye, similar DFT calculations carried out for the mono-protonated analogues indicate that the julolidine residue is the stronger base while the resultant conjugate acid is the weaker one. Absorption and fluorescence spectroscopic titrations show that protonation of the hybrid dye occurs in two well-resolved steps, whereby addition of the first proton introduces a thermodynamic barrier for entry of the second. In the hybrid dye, the pKA values for the respective conjugate acids differ markedly from those derived for the mono-amino-styryl dyes and display negative co-operativity. Effectively, this means that electronic interactions running along the molecular backbone make it more difficult, relative to the individual dyes, to protonate both amino sites. As such, this dye operates as a probe over an unusually wide pH range.

Exciplex emission from a boron dipyrromethene (Bodipy) dye equipped with a dicyanovinyl appendage.

The photophysical properties of a prototypic donor-acceptor dyad, featuring a conventional boron dipyrromethene (Bodipy) dye linked to a dicyanovinyl unit through a meso-phenylene ring, have been recorded in weakly polar solvents. The absorption spectrum remains unperturbed relative to that of the parent Bodipy dye but the fluorescence is extensively quenched. At room temperature, the emission spectrum comprises roughly equal contributions from the regular π, π* excited-singlet state and from an exciplex formed by partial charge transfer from Bodipy to the dicyanovinyl residue. This mixture moves progressively in favor of the locally excited π, π* state on cooling and the exciplex is no longer seen in frozen media; the overall emission quantum yield changes dramatically near the freezing point of the solvent. The exciplex, which has a lifetime of approximately 1 ns at room temperature, can also be seen by transient absorption spectroscopy, in which it decays to form the locally excited triplet state. Under applied pressure (P<170 MPa), formation of the exciplex is somewhat hindered by restricted rotation around the semirigid linkage and again the emission profile shifts in favor of the π, π* excited state. At higher pressure (170

Charge-recombination fluorescence from push-pull electronic systems constructed around amino-substituted styryl-BODIPY dyes.

A small series of donor-acceptor molecular dyads has been synthesized and fully characterized. In each case, the acceptor is a dicyanovinyl unit and the donor is a boron dipyrromethene (BODIPY) dye equipped with a single styryl arm bearing a terminal amino group. In the absence of the acceptor, the BODIPY-based dyes are strongly fluorescent in the far-red region and the relaxed excited-singlet states possess significant charge-transfer character. As such, the emission maxima depend on both the solvent polarity and temperature. With the corresponding push-pull molecules, there is a low-energy charge-transfer state that can be observed by both absorption and emission spectroscopy. Here, charge-recombination fluorescence is weak and decays over a few hundred picoseconds or so to recover the ground state. Overall, these results permit evaluation of the factors affecting the probability of charge-recombination fluorescence in push-pull dyes. The photophysical studies are supported by cyclic voltammetry and DFT calculations.